Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
34201 | 76 | 33.6 | 58% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
1032 | 9719 | METABOLIC SYNDROME//WAIST CIRCUMFERENCE//ABDOMINAL OBESITY |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | TURKISH SOC CARDIOL | Address | 2 | 25% | 11% | 8 |
2 | EXECUTIVE STRESS | Author keyword | 1 | 50% | 1% | 1 |
3 | MINNESOTA CODING | Author keyword | 1 | 50% | 1% | 1 |
4 | SIYAMI ERSEK CARDIOVASC SURG | Address | 1 | 50% | 1% | 1 |
5 | PROINFLAMMATORY STATE | Author keyword | 0 | 20% | 3% | 2 |
6 | 418 | Address | 0 | 33% | 1% | 1 |
7 | SUPPORTIVE CARE IN CANCER | Author keyword | 0 | 33% | 1% | 1 |
8 | GRP INVEST FARMACOEPIDEMIOL FARMACOVIGILANCIA | Address | 0 | 15% | 3% | 2 |
9 | AUTOIMMUNE ACTIVATION | Author keyword | 0 | 25% | 1% | 1 |
10 | CERR ASA MED | Address | 0 | 20% | 1% | 1 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | EXECUTIVE STRESS | 1 | 50% | 1% | 1 | Search EXECUTIVE+STRESS | Search EXECUTIVE+STRESS |
2 | MINNESOTA CODING | 1 | 50% | 1% | 1 | Search MINNESOTA+CODING | Search MINNESOTA+CODING |
3 | PROINFLAMMATORY STATE | 0 | 20% | 3% | 2 | Search PROINFLAMMATORY+STATE | Search PROINFLAMMATORY+STATE |
4 | SUPPORTIVE CARE IN CANCER | 0 | 33% | 1% | 1 | Search SUPPORTIVE+CARE+IN+CANCER | Search SUPPORTIVE+CARE+IN+CANCER |
5 | AUTOIMMUNE ACTIVATION | 0 | 25% | 1% | 1 | Search AUTOIMMUNE+ACTIVATION | Search AUTOIMMUNE+ACTIVATION |
6 | DRUGS WITH PRESCRIPTION | 0 | 13% | 1% | 1 | Search DRUGS+WITH+PRESCRIPTION | Search DRUGS+WITH+PRESCRIPTION |
7 | TURKISH ADULTS | 0 | 11% | 1% | 1 | Search TURKISH+ADULTS | Search TURKISH+ADULTS |
8 | APOAI LDL | 0 | 100% | 1% | 1 | Search APOAI+LDL | Search APOAI+LDL |
9 | APOLIPOPROTEIN E CONCENTRATIONS | 0 | 100% | 1% | 1 | Search APOLIPOPROTEIN+E+CONCENTRATIONS | Search APOLIPOPROTEIN+E+CONCENTRATIONS |
10 | APOLIPOPROTEINS A I B AND E | 0 | 100% | 1% | 1 | Search APOLIPOPROTEINS+A+I++B++AND+E | Search APOLIPOPROTEINS+A+I++B++AND+E |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | ELEVATED HEPATIC LIPASE | 1 | 29% | 5% | 4 |
2 | TURKISH MEN | 1 | 33% | 3% | 2 |
3 | FATTY LIVER INDEX | 0 | 33% | 1% | 1 |
4 | EUROASPIRE | 0 | 25% | 1% | 1 |
5 | TURKS | 0 | 11% | 1% | 1 |
6 | HDL PHOSPHOLIPIDS | 0 | 100% | 1% | 1 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
---|---|---|---|---|
Atherosclerotic Vascular Disease and Risk Factors in Turkey: From Past to Present | 2008 | 12 | 13 | 31% |
Managing the Maternal Body: A Comprehensive Review and Transdisciplinary Analysis | 2011 | 15 | 41 | 12% |
Risk factors and cardiovascular disease in Turkey | 2001 | 156 | 24 | 25% |
REFRAMING THE GLASS CEILING AS A SOCIALLY CONSTRUCTED PROCESS - IMPLICATIONS FOR UNDERSTANDING AND CHANGE | 1995 | 19 | 33 | 6% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | TURKISH SOC CARDIOL | 2 | 25% | 11% | 8 |
2 | SIYAMI ERSEK CARDIOVASC SURG | 1 | 50% | 1.3% | 1 |
3 | 418 | 0 | 33% | 1.3% | 1 |
4 | GRP INVEST FARMACOEPIDEMIOL FARMACOVIGILANCIA | 0 | 15% | 2.6% | 2 |
5 | CERR ASA MED | 0 | 20% | 1.3% | 1 |
6 | DOCTORAL PROGRAMMES | 0 | 20% | 1.3% | 1 |
7 | PRAXISKLIN HERZ GEFASSE | 0 | 14% | 1.3% | 1 |
8 | GRP PHARMACOEPIDEMIOL PHARMACOSURVEILLANCE | 0 | 100% | 1.3% | 1 |
9 | LIPIDOS DIABETPHYSIOL SCI | 0 | 100% | 1.3% | 1 |
10 | TURK KARDIYOL DEMEGI | 0 | 100% | 1.3% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000113065 | ASIAN JOURNAL OF WOMENS STUDIES//ASIAN FEMINISM//ASIAN WOMENS STUDIES |
2 | 0.0000107457 | WEEKEND DAYS//PREVENT CARDIOL ADULTS//IONOME |
3 | 0.0000095684 | TORCETRAPIB//HIGH DENSITY LIPOPROTEIN//ANACETRAPIB |
4 | 0.0000094280 | TG HDL C RATIO//TRIGLYCERIDE TO HDL CHOLESTEROL RATIO//DEOB |
5 | 0.0000093644 | ATTITUDES TO WORK//FIRST LADY//MICHELLE OBAMA |
6 | 0.0000090518 | IST MED INTERNA VASCOLARE//AALENS MODEL//ADJUSTED SURVIVAL |
7 | 0.0000084307 | EDTA CHELATION//DIPARTIMENTO MORFOL UMANA SCI BIOMED CITTA//SURROGATE CRITERIA |
8 | 0.0000083236 | ACYLATION STIMULATING PROTEIN//C3ADESARG//MIKE ROSENBLOOM CARDIOVASC |
9 | 0.0000082919 | HLTH BUR NANDAN CTY//BANTUS//DIETARY LIPID INTAKE |
10 | 0.0000082694 | MATERNITY LEAVE//FAMILY GAP//CAREER INTERRUPTION |